1. Home
  2. BRAG vs LGVN Comparison

BRAG vs LGVN Comparison

Compare BRAG & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bragg Gaming Group Inc.

BRAG

Bragg Gaming Group Inc.

HOLD

Current Price

$1.73

Market Cap

41.5M

Sector

Technology

ML Signal

HOLD

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$1.13

Market Cap

34.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRAG
LGVN
Founded
2018
2014
Country
Canada
United States
Employees
N/A
38
Industry
Office Equipment/Supplies/Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.5M
34.0M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
BRAG
LGVN
Price
$1.73
$1.13
Analyst Decision
Hold
Strong Buy
Analyst Count
2
1
Target Price
$6.00
$3.00
AVG Volume (30 Days)
32.8K
9.2M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.76
EPS
N/A
N/A
Revenue
N/A
$709,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.13
$10.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$0.48
52 Week High
$4.82
$1.83

Technical Indicators

Market Signals
Indicator
BRAG
LGVN
Relative Strength Index (RSI) 48.21 62.58
Support Level $1.56 $0.55
Resistance Level $2.22 $1.22
Average True Range (ATR) 0.18 0.11
MACD -0.00 0.01
Stochastic Oscillator 26.70 72.97

Price Performance

Historical Comparison
BRAG
LGVN

About BRAG Bragg Gaming Group Inc.

Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, the United States, Croatia, and other regions.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: